The challenges halting clinical trial progress in ALL - 101793

Spotlight
Video

The challenges halting clinical trial progress in ALL

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: Oliver Ottmann, MD, FRCPath, of Cardiff University, Cardiff, UK, raises the issue of slow progression of clinical trials in acute lymphoblastic leukemia (ALL) and the factors that play a part. Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Prof. Ottmann alludes to the lack of funding that presents a particular challenge regarding this topic.
Shared By : VJHemOnc
Posted on : 08/24/18
Added : 10 months ago